Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-027016
Filing Date
2017-11-20
Accepted
2017-11-20 17:43:36
Documents
1
Period of Report
2017-11-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 17268
  Complete submission text file 0000899243-17-027016.txt   18631
Mailing Address 890 WINTER STREET, SUITE 230 WALTHAM MA 02451
Business Address 890 WINTER STREET, SUITE 230 WALTHAM MA 02451 781-819-5704
Arsanis, Inc. (Issuer) CIK: 0001501697 (see all company filings)

EIN.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ARSANIS, INC. 890 WINTER STREET, SUITE 230 WALTHAM MA 02451
Business Address
Nessi Claudio (Reporting) CIK: 0001722050 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38295 | Film No.: 171214911